trial

[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis

NCTId NCT02880995
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 62 (estimated)
Sponsored by Seoul National University Hospital
Primary completion 2019-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
62 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2017-11-01
Primary completion
2019-12
Eligibility
ALL · 19 Years · 35 Years

Interventions & indications

Drugs
PET Scanclinical scaleAmisulpride

Sponsors

Seoul National University HospitalLead Sponsor

Investigators

1
Euitae Kim, Ph. D.Study Chair

Sites

2 total
Seongnam-si, South KoreaSeongnam, South Korea

Facts & assertions

4 sourced
Enrollment
62
Phase
NA
Primary Completion Date
2019-12
Status
UNKNOWN
relationships
The graph out of here
drug
PET Scan
drug
clinical scale
drug
Amisulpride
drug
lead_sponsor
Seoul National University Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Euitae Kim, Ph. D.
person